Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YBL019W | APN2 | SGDID:S000000115 | INPPL1 SHIP2 |
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2) |
3.1.3.86 | Homo sapiens | Diabetes Mellitus,Schneckenbecken Dysplasia,Breast Cancer,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Cone-Rod Dystrophy 19,Lowe Oculocerebrorenal Syndrome,Opsismodysplasia |
5okm_b | O15357 | ENSG00000165458 | INPPL1 | 98.60 | 7.80E-12 | 5.90E-16 | 128.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YBL019W | APN2 | SGDID:S000000115 | RNA-directed DNA polymerase homolog (R1) (EC 2.7.7.49) |
RNA-directed DNA polymerase homolog (R1) (EC 2.7.7.49) |
2.7.7.49 | Bombyx mori | 2ei9_a | Q7M4J4 | 98.70 | 2.20E-12 | 1.70E-16 | 118.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | CNOT6L CCR4B |
CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4) (Carbon catabolite repressor protein 4 homolog B) |
3.1.13.4 | Homo sapiens | 5dv4_a | Q96LI5 | ENSG00000138767 | CNOT6L | 99.00 | 1.10E-13 | 8.30E-18 | 139.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YBL019W | APN2 | SGDID:S000000115 | APEX1 APE APE1 APEX APX HAP1 REF1 |
DNA-(apurinic or apyrimidinic site) endonuclease (EC 3.1.-.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial] |
3.1.-.- | Homo sapiens | Cheilitis,Amyotrophic Lateral Sclerosis 1,Senile Cataract,Differentiated Thyroid Carcinoma,Pediatric T-Cell Leukemia,Spinocerebellar Ataxia Type 1 With Axonal Neuropathy,Acoustic Neuroma,Cystic Fibrosis,Actinobacillosis,Pediatric Ependymoma,Cockayne Syndrome,Actinic Cheilitis,Colorectal Cancer,Attenuated Familial Adenomatous Polyposis,Xeroderma Pigmentosum, Complementation Group D,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Xeroderma Pigmentosum, Complementation Group G,Respiratory Failure,Cockayne Syndrome B,Ataxia, Early-Onset, With Oculomotor Apraxia And Hypoalbuminemia,Lung Cancer |
1hd7_a | P27695 | 99.50 | 1.90E-18 | 1.50E-22 | 165.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
YBL019W | APN2 | SGDID:S000000115 | APEX1 APE APE1 APEX APX HAP1 REF1 |
DNA-(apurinic or apyrimidinic site) endonuclease (EC 3.1.-.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial] |
3.1.-.- | Homo sapiens | Cheilitis,Amyotrophic Lateral Sclerosis 1,Senile Cataract,Differentiated Thyroid Carcinoma,Pediatric T-Cell Leukemia,Spinocerebellar Ataxia Type 1 With Axonal Neuropathy,Acoustic Neuroma,Cystic Fibrosis,Actinobacillosis,Pediatric Ependymoma,Cockayne Syndrome,Actinic Cheilitis,Colorectal Cancer,Attenuated Familial Adenomatous Polyposis,Xeroderma Pigmentosum, Complementation Group D,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Xeroderma Pigmentosum, Complementation Group G,Respiratory Failure,Cockayne Syndrome B,Ataxia, Early-Onset, With Oculomotor Apraxia And Hypoalbuminemia,Lung Cancer |
4qhe_a | P27695 | ENSG00000100823 | APEX1 | 99.50 | 3.50E-18 | 2.80E-22 | 161.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YBL019W | APN2 | SGDID:S000000115 | Y63D3A.4 |
5'-tyrosyl-DNA phosphodiesterase (5'-Tyr-DNA phosphodiesterase) (EC 3.1.4.-) |
3.1.4.- | Caenorhabditis elegans | 4fva_a | Q9XWG3 | 98.90 | 1.50E-13 | 1.20E-17 | 127.00 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | LORF2 |
LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)] |
2.7.7.49 | Homo sapiens | 1vyb_a | O00370 | 99.30 | 4.90E-16 | 3.90E-20 | 141.90 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | PDE12 |
2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4) |
3.1.13.4 | Homo sapiens | Rasopathy,Noonan Syndrome 1,Noonan Syndrome 2,Microphthalmia With Limb Anomalies |
4z0v_a | Q6L8Q7 | ENSG00000174840 | PDE12 | 98.80 | 9.90E-13 | 7.40E-17 | 134.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YBL019W | APN2 | SGDID:S000000115 | INPP5D SHIP SHIP1 |
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (EC 3.1.3.86) (Inositol polyphosphate-5-phosphatase D) (EC 3.1.3.56) (Inositol polyphosphate-5-phosphatase of 145 kDa) (SIP-145) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (SH2 domain-containing inositol 5'-phosphatase 1) (SH2 domain-containing inositol phosphatase 1) (SHIP-1) (p150Ship) (hp51CN) |
3.1.3.36,3.1.3.56,3.1.3.86 | Homo sapiens | Leukemia, Chronic Myeloid,Leukemia, Acute Lymphoblastic,Crohn'S Disease,Inflammatory Bowel Disease,Severe Congenital Neutropenia,Juvenile Myelomonocytic Leukemia,Lymphoproliferative Syndrome |
6ibd_a | Q92835 | ENSG00000168918 | INPP5D | 98.70 | 6.10E-12 | 4.50E-16 | 129.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YBL019W | APN2 | SGDID:S000000115 | DNASE1 DNL1 |
Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) |
3.1.21.1 | Bos taurus | 3w3d_b | P00639 | 98.50 | 5.00E-11 | 3.90E-15 | 110.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | smcL |
Sphingomyelinase C (SMase) (EC 3.1.4.12) (Sphingomyelin phosphodiesterase) |
3.1.4.12 | Listeria ivanovii | 1zwx_a | Q9RLV9 | 99.00 | 9.20E-14 | 7.20E-18 | 132.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | Lebu_1528 |
Lebu_1528 |
Leptotrichia buccalis | 3teb_b | C7NB70 | 99.00 | 5.90E-14 | 4.60E-18 | 130.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | crc exoA ALP65_01013 C0044_39460 CAZ10_32350 CGU42_22755 DT376_09125 DZ962_18070 E4V10_18585 ECC04_031800 IPC1164_24995 IPC116_23795 IPC1295_10410 IPC1323_08650 IPC1481_08100 IPC1505_29825 IPC1509_28695 IPC151_23655 IPC36_11985 IPC582_05645 IPC620_03665 IPC669_00200 IPC737_07685 NCTC13621_05232 PA52Ts2_6132 PAMH19_3299 RW109_RW109_06940 |
crc exoA ALP65_01013 C0044_39460 CAZ10_32350 CGU42_22755 DT376_09125 DZ962_18070 E4V10_18585 ECC04_031800 IPC1164_24995 IPC116_23795 IPC1295_10410 IPC1323_08650 IPC1481_08100 IPC1505_29825 IPC1509_28695 IPC151_23655 IPC36_11985 IPC582_05645 IPC620_03665 IPC669_00200 IPC737_07685 NCTC13621_05232 PA52Ts2_6132 PAMH19_3299 RW109_RW109_06940 |
3.1.11.2 | Pseudomonas aeruginosa | 4jg3_a | Q51380 | 99.50 | 4.40E-18 | 3.40E-22 | 158.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | AF_0580 |
AF_0580 |
Archaeoglobus fulgidus | 2voa_a | O29675 | 99.30 | 1.20E-16 | 9.10E-21 | 148.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | MM_3148 |
MM_3148 |
3.1.11.2 | Methanosarcina mazei | 5j8n_a | Q8PSD1 | 99.40 | 1.60E-17 | 1.20E-21 | 154.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | INPP5E |
Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86) |
3.1.3.36,3.1.3.86, | Homo sapiens | Polycystic Kidney Disease,Coach Syndrome 1,Bardet-Biedl Syndrome,Clubfoot,Cohen Syndrome,Renal Dysplasia, Cystic,Familial Clubfoot With Or Without Associated Lower Limb Anomalies,Joubert Syndrome 3,Retinal Ciliopathy,Nephronophthisis,Leber Plus Disease,Posterior Pituitary Gland Neoplasm,Fundus Dystrophy,Interstitial Lung Disease,Spinocerebellar Ataxia 29,Parkinson Disease 20, Early-Onset,Respiratory Failure,Cleft Palate, Isolated,Dent Disease 1,Clubfoot, Congenital, With Or Without Deficiency Of Long Bones And/Or Mirror-Image Polydactyly,Mental Retardation, Truncal Obesity, Retinal Dystrophy, And Micropenis Syndrome,Polydactyly,Macrocephaly/Autism Syndrome,Odontochondrodysplasia,Patent Ductus Arteriosus 1,Lowe Oculocerebrorenal Syndrome,Behr Syndrome,Joubert Syndrome 1 |
2xsw_a | Q9NRR6 | ENSG00000148384 | INPP5E | 98.90 | 1.30E-13 | 9.80E-18 | 136.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YBL019W | APN2 | SGDID:S000000115 | Beta-hemolysin |
Beta-hemolysin |
Staphylococcus aureus | 3i41_a | A7LAI8 | 99.00 | 4.30E-14 | 3.30E-18 | 136.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | OCRL OCRL1 |
Inositol polyphosphate 5-phosphatase OCRL (EC 3.1.3.36) (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase OCRL-1) (OCRL-1) (Lowe oculocerebrorenal syndrome protein) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (EC 3.1.3.86) |
3.1.3.36,3.1.3.56,3.1.3.86 | Homo sapiens | Cataract-Glaucoma,X-Linked Recessive Disease,Renal Tubular Transport Disease,Legionnaire Disease,Nephrocalcinosis,Cataract,Cystinuria,Donnai-Barrow Syndrome,Rickets,Fanconi Syndrome,Aminoaciduria,Chromosome 14q11-Q22 Deletion Syndrome,Renal Tubular Acidosis,Lens Disease,Dent Disease 1,Hydrophthalmos,Disease Of Mental Health,Glaucoma 3, Primary Congenital, A,Hypophosphatemic Rickets, X-Linked Recessive,Dent Disease 2,Aniseikonia,Hypophosphatemia,X-Linked Monogenic Disease,Lowe Oculocerebrorenal Syndrome |
4cmn_a | Q01968 | ENSG00000122126 | OCRL | 98.70 | 5.10E-12 | 3.80E-16 | 124.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YBL019W | APN2 | SGDID:S000000115 | LmAP LMJF_16_0680 |
LmAP LMJF_16_0680 |
3.1.-.- | Leishmania major | 2j63_a | O15922 | 99.50 | 2.40E-18 | 1.70E-22 | 178.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | EF_1237 |
EF_1237 |
Enterococcus faecalis | 3l1w_d | Q835Y1 | 99.00 | 1.10E-13 | 8.70E-18 | 127.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | Tdp2 Ttrap |
Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein) |
3.1.4.- | Mus musculus | 4puq_a | Q9JJX7 | 99.00 | 8.90E-14 | 7.00E-18 | 128.20 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | BVU_0621 |
BVU_0621 |
Bacteroides vulgatus | 3g6s_a | A6KY15 | 98.90 | 3.00E-13 | 2.30E-17 | 125.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | INPP5B OCRL2 |
Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase) (5PTase) |
3.1.3.36 | Homo sapiens | X-Linked Recessive Disease,Amyotrophic Lateral Sclerosis 11,Yunis-Varon Syndrome,Amyotrophic Lateral Sclerosis 1,Charcot-Marie-Tooth Disease, Type 4b3,Fanconi Syndrome,Dent Disease 1,Dent Disease 2,Charcot-Marie-Tooth Disease, Type 4j,Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 3,Lowe Oculocerebrorenal Syndrome,Charcot-Marie-Tooth Disease, Axonal, Type 2e,Joubert Syndrome 1 |
4cml_a | P32019 | ENSG00000204084 | INPP5B | 98.80 | 1.00E-12 | 7.70E-17 | 127.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YBL019W | APN2 | SGDID:S000000115 | cdtB |
cdtB |
Haemophilus ducreyi | 1sr4_b | O06523 | 99.00 | 1.00E-13 | 7.80E-18 | 130.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | exoA NMB2082 |
exoA NMB2082 |
3.1.11.2 | Neisseria meningitidis | 2jc5_a | Q7DD47 | 99.50 | 1.80E-18 | 1.40E-22 | 160.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | ORF2 |
ORF2 |
Bombyx mori | 1wdu_b | Q93139 | 99.20 | 3.80E-15 | 3.00E-19 | 136.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | sph |
Sphingomyelinase C (SMase) (EC 3.1.4.12) (Cereolysin B) (SMPLC) (Sphingomyelin phosphodiesterase) |
3.1.4.12 | Bacillus cereus | 2ddr_a | P11889 | 98.90 | 4.90E-13 | 3.80E-17 | 127.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | NOCT CCR4 CCRN4L NOC |
Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein) |
3.1.3.- | Homo sapiens | 6bt1_a | Q9UK39 | ENSG00000151014 | NOCT | 98.90 | 2.00E-13 | 1.60E-17 | 130.60 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YBL019W | APN2 | SGDID:S000000115 | SiRe_0100 |
SiRe_0100 |
Sulfolobus islandicus | 5ewt_a | F0NG49 | 99.30 | 8.80E-17 | 6.90E-21 | 148.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | tdp2 ttrap ttrapl si:ch211-81e5.5 si:dkey-218n20.5 |
Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein homolog) |
3.1.4.- | Danio rerio | 4f1h_a | Q5XJA0 | 98.80 | 6.10E-13 | 4.80E-17 | 121.70 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | NP |
Nitrophorin Cim l NP (NP) (Salivary nitrophorin) (cNP) (allergen Cim l NP) |
Cimex lectularius | 2imq_x | O76745 | 99.00 | 1.20E-13 | 9.60E-18 | 130.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | cdtB STY1886 t1111 |
Cytolethal distending toxin subunit B homolog (CDT B) (Deoxyribonuclease CdtB) (EC 3.1.-.-) |
3.1.-.- | Salmonella typhi | 4k6l_f | Q8Z6A7 | 98.80 | 7.10E-13 | 5.50E-17 | 123.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | SMPD3 |
Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II) |
3.1.4.12 | Homo sapiens | Dentinogenesis Imperfecta,Aggressive Systemic Mastocytosis,Farber Lipogranulomatosis,Brittle Bone Disorder,Coffin-Siris Syndrome 1,Pituitary Hormone Deficiency, Combined, 2 |
5uvg_a | Q9NY59 | 99.00 | 6.90E-14 | 5.20E-18 | 139.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
YBL019W | APN2 | SGDID:S000000115 | Bcav_3678 |
Bcav_3678 |
Beutenbergia cavernae | 4ruw_a | C5C3L1 | 99.10 | 2.60E-14 | 1.90E-18 | 146.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | cdtB |
Cytolethal distending toxin subunit B (CDT B) (Deoxyribonuclease CdtB) (EC 3.1.-.-) |
3.1.-.- | Escherichia coli | 2f1n_a | Q46669 | 99.00 | 8.70E-14 | 6.60E-18 | 131.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||
YBL019W | APN2 | SGDID:S000000115 | MTH_212 |
DNA uridine endonuclease (DNA U-endo) (DNA U-endonuclease) (AP endonuclease) (EC 4.2.99.18) (ExoMt) (EC 3.1.11.2) |
3.1.11.2,4.2.99.18, | Methanothermobacter thermautotrophicus | 3g91_a | O26314 | 99.40 | 1.80E-17 | 1.40E-21 | 154.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | BT_3783 |
BT_3783 |
Bacteroides thetaiotaomicron | 3mpr_a | Q8A183 | 98.90 | 2.80E-13 | 2.20E-17 | 129.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YBL019W | APN2 | SGDID:S000000115 | xthA NMB0399 |
xthA NMB0399 |
3.1.11.2 | Neisseria meningitidis | 2jc4_a | Q9K100 | 99.30 | 1.60E-16 | 1.20E-20 | 146.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | smc |
smc |
3.1.4.12 | Streptomyces griseocarneus | 3wcx_a | A6P7M9 | 99.00 | 5.60E-14 | 4.40E-18 | 133.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YBL019W | APN2 | SGDID:S000000115 | exoA BSU40880 |
Exodeoxyribonuclease (EC 3.1.11.2) |
3.1.11.2 | Bacillus subtilis | 5cfe_a | P37454 | 99.30 | 2.60E-16 | 2.00E-20 | 145.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |